Coronavirus

3rd-Phase Human Trial Of Covaxin Begins In Bhubaneswar’s SUM Hospital

Bhubaneswar: The third-phase human trial of Covaxin, the indigenous vaccine being developed against COVID-19 by ICMR and Bharat Biotech, has begun at IMS & SUM Hospital here.

The vaccine was administered to two recruits at the Preventive and Therapeutic Clinical Trial Unit (PTCTU) at the hospital, Dr E Venkata Rao, Principal Investigator in Covaxin human trial, said.

He further said the vaccine’s first phase trial primarily looked at its safety aspect for human use without any significant side effect, while Phase 2 measured the antibody level in the human blood and checked whether it was sufficient to protect the person from the infection. The third phase trial would check the efficacy of the vaccine.

“In fact, phase three of the trial is crucial and tedious as we have to wait till the development of the disease which was dependent on the frequency of the disease in the population. So we need to recruit a large number of subjects and more than 25,000 volunteers were being recruited for the trial across the country,” Prof Rao said.

In phase three, two doses would be administered to each volunteer 28 days apart but the follow-up period would extend to 12 months to look at its long term and side effects, he said.

Prof. Rao said that Covaxin was an inactivated whole-cell virion without the ability to produce the disease but helped in developing antibodies against the infection. These are time-tested vaccines while the others being developed were mRNA vaccines, new to the human population, which send a signal into the human cell for the production of antibodies against the disease.

While recruiting volunteers for the phase three trial, the restriction of being
a healthy volunteer was not mandatory. Anyone with diabetes or hypertension or
with any other disease could participate in the trial provided the disease was
under control in them with medication, he said.

Volunteers desirous of participating in the trial could register on-line on the
portal http://ptctu.soa.ac.in or can send a message through WhatsApp with their
name, age, gender and the place of residence to 7849021450, he added

The institute is one of the 21 medical facilities selected across the country for the efficacy study. It is the only institute in Odisha, which has been picked for this purpose.

OB Bureau

Recent Posts

3 People Including 2 Toddlers Killed After Truck Runs Over Labourers Sleeping On Pune Footpath

Pune: Three people, including two toddlers, died on Monday when a dumper truck run over…

13 minutes ago

3 Khalistani Terrorists Involved In Attack On Punjab’s Police Station Killed In Encounter In Uttar Pradesh

Lucknow: Three terrorists accused of lobbing a grenade at a police post in Punjab’s Gurdaspur…

31 minutes ago

Odisha: Malkangiri-Visakhapatnam Air Connectivity May Become A Reality In 2025

Malkangiri: If things go as per plan, flight services between Odisha’s Malkangiri town and Visakhapatnam…

53 minutes ago

Miscreants Attack Man, Kidnap Female Friend In Odisha Capital

Bhubaneswar: Unidentified miscreants allegedly attacked a man and kidnapped his female friend in Maitri Vihar…

1 hour ago

Youth Beaten To Death On Suspicion Of Theft At Shop In Odisha’s Balasore

Balasore: A young man was allegedly beaten to death on the suspicion of having committed…

2 hours ago

When A ‘Powerful Man’s Wife’ Broke Into Varun Dhawan’s House To Elope With Actor!

Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…

15 hours ago

This website uses cookies.